Last reviewed · How we verify

Injection of Pegfilgrastim

Centre Leon Berard · Phase 2 active Small molecule

Injection of Pegfilgrastim is a Small molecule drug developed by Centre Leon Berard. It is currently in Phase 2 development.

At a glance

Generic nameInjection of Pegfilgrastim
SponsorCentre Leon Berard
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Injection of Pegfilgrastim

What is Injection of Pegfilgrastim?

Injection of Pegfilgrastim is a Small molecule drug developed by Centre Leon Berard.

Who makes Injection of Pegfilgrastim?

Injection of Pegfilgrastim is developed by Centre Leon Berard (see full Centre Leon Berard pipeline at /company/centre-leon-berard).

What development phase is Injection of Pegfilgrastim in?

Injection of Pegfilgrastim is in Phase 2.

Related